IRVINE, Calif., Feb. 9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. today announced that it will release fourth quarter and year-end 2005 financial results on February 23, 2006 before the U.S. markets open. ISTA will host a conference call with a simultaneous webcast to discuss these results at 10:30 a.m. Eastern Time on February 23.
To access the live conference call, U.S. and Canadian participants may dial 800-291-5365; international participants may dial 617-614-3922. The access code for the live call is 59935540. To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 81379873. This conference call will also be webcast live and archived on ISTA's Web site until March 23, 2006 at http://www.istavision.com.
ABOUT ISTA
ISTA is a specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products. ISTA's products and product candidates seek to address serious diseases and conditions of the eye such as dry eye, vitreous hemorrhage, diabetic retinopathy, hyphema, glaucoma, pain and inflammation. Building on this pipeline, ISTA's goal is to continue its growth as a specialty pharmaceutical company by acquiring complementary products, either already marketed or in late-stage development. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' Website at http://www.istavision.com/.
ISTA Pharmaceuticals, Inc.CONTACT: Vince Anido, +1-949-788-5311, vanido@istavision.com, or LaurenSilvernail, +1-949-788-5302, lsilvernail@istavision.com, both of ISTAPharmaceuticals; or Justin Jackson, Media, jjackson@burnsmc.com, or LisaBurns Investors, or Laura Siino, lsiino@burnsmc.com, +1-212-213-0006, allof Burns McClellan for ISTA Pharmaceuticals
Web site: http://www.istavision.com/
